Caristo Diagnostics Ltd.

Caristo Diagnostics Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on February 20, 2025 and the most recent on February 20, 2025 (CaRi-Plaque). Its most common review panel is Radiology (1 device).